The Wet Seal, Inc. (NASDAQ:WTSL) rebounded on the last day of the trading week on 28th after investors found the stock to be priced appropriately, post its nearly 23 percent dip in valuation ever since it reported its 4Q and full year operational results on 20th march The Wet Seal, Inc. (NASDAQ:WTSL) shares after opening at $1.31 moved to $1.32 on last trade day and at the end of the day closed at $1.21. Company price to sales ratio in past twelve months was calculated as 0.19 and price to cash ratio as 2.22. The Wet Seal, Inc. (NASDAQ:WTSL) showed a positive weekly performance of 1.68%.
Maxim Group has reaffirmed their “buy” rating on Agenus Inc (NASDAQ:AGEN) shares in the report that was issued to investors. The company has been the subject of numerous other recent-research reports. The analysts at the MLV & Co. firm have upped their price target on Agenus Inc (NASDAQ:AGEN) shares from $9.00 up to $11.00 in the research note on 14 March. They have set a rating of “buy” on the company stock. The analysts at the HC Wainwright firm have initiated their coverage on Agenus Inc (NASDAQ:AGEN) shares in the research note on 24 February. They currently have a rating of “buy” on the stock with the price target of $8.00 on the stock. Agenus Inc (NASDAQ:AGEN) shares fell -4.67% in last trading session and ended the day on $3.06. AGEN return on equity ratio is recorded as 318.50% and its return on assets is -141.80%. Agenus Inc (NASDAQ:AGEN) yearly performance is -21.74%.
On Mar 26,2014 Investors in Uranium Energy Corp (NYSEMKT:UEC) saw new options become available this week, for the November 22nd expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 241 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the UEC options chain for the new November 22nd contracts and identified the following call contract of particular interest. Uranium Energy Corp. (NYSEMKT:UEC) shares moved down -5.19% in last trading session and was closed at $1.28, while trading in range of $1.27-$1.39. Uranium Energy Corp. (NYSEMKT:UEC) year to date performance is -36.00%.
Galena Biopharma (Nasdaq:GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, today announced that Mark J. Ahn, Ph.D., President and Chief Executive Officer will present a corporate update at the 13th Annual Needham Healthcare Conference. The presentation will take place on Tuesday, April 8, 2014 at 8:40 a.m. ET at the Westin Grand Central Hotel in New York, NY. Galena Biopharma Inc (NASDAQ:GALE) weekly performance is 0.42%. On last trading day company shares ended up $2.38. Galena Biopharma Inc (NASDAQ:GALE) distance from 50-day simple moving average is -38.65%. Analysts mean target price for the company is $6.67.